Clinical Trial: Platelets and Extracorporeal Membrane Oxygenation Veno-venous

U.S., May 13 -- ClinicalTrials.gov registry received information related to the study (NCT07580469) titled 'Platelets and Extracorporeal Membrane Oxygenation Veno-venous' on April 27.

Brief Summary: In severe lung or heart disease, ExtraCorporeal Membrane Oxygenation (ECMO) may be used temporarily and can be responsible for major haemorrhagic complications. Thrombocytopenia and possibly thrombopathy promote bleeding. The primary objective is to characterize platelet dysfunction by aggregometry tests over time. Secondarily, investigators seek a correlation between haemorrhagic complications at day 10 and markers of platelet action and dysfunction; also, with the level of anticoagulation and inflammation by biomarkers.

Study Start Date: May...